Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CTL | CTL Administration | 18/05/21 | 23 | 11K | |||
|
|||||||
CTL | Ann: Update on the DOCA and Meeting of Creditors | 29/03/20 | 11 | 10K | |||
|
|||||||
CTL | Ann: Removal from Official List - Annual Listing Fees | 23/02/20 | 56 | 30K | |||
|
|||||||
CTL | Ann: DOCA Update | 27/08/19 | 5 | 4.3K | |||
|
|||||||
CTL | DOCA Update - CTL Potentially Merging with AUL | 23/08/19 | 2 | 1.7K | |||
|
|||||||
CTL | Ann: DOCA Update | 20/08/19 | 29 | 20K | |||
|
|||||||
CTL | Ann: AUL:AuStar enters discussions with Centennial Administrators | 08/08/19 | 18 | 7.6K | |||
|
|||||||
CTL | Audit inquiry | 02/08/19 | 0 | 685 | |||
|
See All Discussions